Literature DB >> 21285908

Extracardiac abnormalities on rubidium-82 cardiac positron emission tomography/computed tomography.

Sahar Mirpour1, Amir H Khandani.   

Abstract

BACKGROUND: The role of rubidium-82 (Rb) in recognizing extracardiac diseases is minimally investigated. The aim of this study was to evaluate the frequency and incremental added value of extracardiac findings on Rb cardiac positron emission tomography/computed tomography (PET/CT) studies.
METHOD: The study included all consecutive patients who were referred from July 2008 to June 2010 for Rb cardiac PET/CT to our institution. A blinded reader reviewed the images retrospectively to assess abnormal extracardiac PET findings.
RESULTS: Images of 406 patients (142 men; 264 women) with a mean age±standard deviation of 59.72±12.93 years (range: 18-91 years) were reviewed. Incidental extracardiac abnormalities were found in 67 of 406 patients (16.5%). Among them, eight patients had malignant etiologies (1.9%).
CONCLUSION: Incidental extracardiac findings were present in a significant portion of patients undergoing Rb cardiac PET/CT studies. Although most of the extracardiac findings on Rb cardiac PET/CT studies represented clinically known pathologies, these incidental findings on routine Rb cardiac PET/CT scans may have a significant clinical impact on a small number of patients, and offer the referring physician the chance to obtain additional clinically relevant information.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285908     DOI: 10.1097/MNM.0b013e3283440dcb

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  11 in total

1.  [11C]Acetate rest-stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats.

Authors:  Etienne Croteau; Suzanne Gascon; M'hamed Bentourkia; Réjean Langlois; Jacques A Rousseau; Roger Lecomte; François Bénard
Journal:  Nucl Med Biol       Date:  2011-11-12       Impact factor: 2.408

2.  Impaired cardiac PET image quality due to delayed (82)Rubidium dose delivery to the heart.

Authors:  Christina Byrne; Lotte Hahn Enevoldsen; Andreas Kjær; Philip Hasbak
Journal:  J Nucl Cardiol       Date:  2015-11-10       Impact factor: 5.952

3.  Rubidium-82 uptake in metastases from neuroendocrine tumors: No flow response to adenosine.

Authors:  Philip Hasbak; Lotte Hahn Enevoldsen; Marie Øbro Fosbøl; Dorthe Skovgaard; Ulrich Peter Knigge; Andreas Kjær
Journal:  J Nucl Cardiol       Date:  2015-09-10       Impact factor: 5.952

4.  Metastatic breast cancer diagnosed by rubidium-82 positron emission tomography myocardial perfusion imaging.

Authors:  Ali Shafiq; Khawaja Afzal Ammar; Lynn Gilles; Nolan Machernis; Debra Mahlum; Panithaya Chareonthaitawee; Steven C Port
Journal:  J Nucl Cardiol       Date:  2017-03-03       Impact factor: 5.952

5.  Incidental extra-cardiac findings on 13N-ammonia myocardial perfusion PET/CT.

Authors:  H Kan; F M van der Zant; M Wondergem; R J J Knol
Journal:  J Nucl Cardiol       Date:  2017-04-07       Impact factor: 5.952

6.  Incidental renal masses on SPECT/CT and PET/CT.

Authors:  Jorge D Oldan; Amir H Khandani
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-06-15

7.  Renal Potassium Excretion Visualized on 82Rubidium PET/CT.

Authors:  Mads Ryø Jochumsen; Lars Poulsen Tolbod; Michael Borre; Jørgen Frøkiær; Kirsten Bouchelouche; Jens Sörensen
Journal:  Nucl Med Mol Imaging       Date:  2020-04-15

8.  Looking outside the "cardiac" box: incidental detection of a metastatic lung tumor on cardiac position emission tomography/computed tomography.

Authors:  Mohamed Shawgi; P Arumugam
Journal:  World J Nucl Med       Date:  2014-09

9.  Application of 82 Sr/82 Rb generator in neurooncology.

Authors:  Nikolay A Kostenikov; Boris L Zhuikov; Valeriy M Chudakov; Yuriy R Iliuschenko; Sergey V Shatik; Vadim V Zaitsev; Dmitriy S Sysoev; Andrey A Stanzhevskiy
Journal:  Brain Behav       Date:  2019-02-06       Impact factor: 2.708

10.  Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density.

Authors:  Mads Ryø Jochumsen; Jens Sörensen; Bodil Ginnerup Pedersen; Jens Randel Nyengaard; Søren Rasmus Palmelund Krag; Jørgen Frøkiær; Michael Borre; Kirsten Bouchelouche; Lars Poulsen Tolbod
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.